ALFACT INNOVATION has a total of 16 patent applications. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are EYETECH PHARMACEUTICALS INC, GLYCOLOGIC LTD and ANGES MG INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | China | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | France | 1 | |
#8 | Hungary | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Amouyal Paul | 15 |
#2 | Brechot Christian | 15 |
#3 | Amouyal Gilles | 15 |
#4 | Faivre Jamila | 14 |
#5 | Jamot Laure | 8 |
#6 | Darnaud Marion | 8 |
#7 | Rougier Elodie | 7 |
#8 | Gressens Pierre | 7 |
#9 | Vibert Eric | 4 |
#10 | Andreelli Fabrizio | 4 |
Publication | Filing date | Title |
---|---|---|
CN105658280A | Composition including the hip/pap protein or one of the derivatives thereof for treating insulin resistance | |
EP2687225A1 | HIP/PAP protein and derivatives thereof for use in treating cancer | |
EP2260857A1 | Novel applications of HIP/PAP or derivatives thereof |